These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 27258508)

  • 1. Identification of High-Risk Subgroups of Patients With Oral Cavity Cancer in Need of Postoperative Adjuvant Radiotherapy or Chemo-Radiotherapy.
    Chen WC; Lai CH; Fang CC; Yang YH; Chen PC; Lee CP; Chen MF
    Medicine (Baltimore); 2016 May; 95(22):e3770. PubMed ID: 27258508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative adjuvant therapy for patients with loco-regionally advanced oral squamous cell carcinoma who are at high risk of recurrence.
    Yanamoto S; Denda Y; Ota Y; Hasegawa T; Akashi M; Okura M; Yamada SI; Kurita H; Yamakawa N; Kirita T; Ueda M; Umeda M;
    Int J Oral Maxillofac Surg; 2020 Jul; 49(7):848-853. PubMed ID: 31926824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative concomitant chemoradiotherapy improved treatment outcomes of patients with oral cavity cancer with multiple-node metastases but no other major risk factors.
    Fan KH; Lin CY; Kang CJ; Lee LY; Huang SF; Liao CT; Chen IH; Ng SH; Wang HM; Chang JT
    PLoS One; 2014; 9(2):e86922. PubMed ID: 24586259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of postoperative chemotherapy and radiotherapy on patients with squamous cell carcinoma of the oral cavity and multiple regional lymph node metastases.
    Takahashi H; Yanamoto S; Yamada S; Umeda M; Shigeta T; Minamikawa T; Shibuya Y; Komori T; Shiraishi T; Asahina I; Yokoo S; Ri S
    Int J Oral Maxillofac Surg; 2014 Jun; 43(6):680-5. PubMed ID: 24387949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter Retrospective Study of Adjuvant Therapy for Patients with Pathologically Lymph Node-Positive Oral Squamous Cell Carcinoma: Analysis of Covariance Using Propensity Score.
    Yanamoto S; Otsuru M; Ota Y; Okura M; Aikawa T; Kurita H; Kamata T; Kirita T; Yamakawa N; Ueda M; Yamashita T; Komori T; Shigeta T; Yokoo S; Ogawa M; Umeda M;
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S992-9. PubMed ID: 26289809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival.
    Brandwein-Gensler M; Teixeira MS; Lewis CM; Lee B; Rolnitzky L; Hille JJ; Genden E; Urken ML; Wang BY
    Am J Surg Pathol; 2005 Feb; 29(2):167-78. PubMed ID: 15644773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative radiotherapy with or without concurrent chemotherapy for oral squamous cell carcinoma in patients with three or more minor risk factors: a propensity score matching analysis.
    Fan KH; Chen YC; Lin CY; Kang CJ; Lee LY; Huang SF; Liao CT; Ng SH; Wang HM; Chang JT
    Radiat Oncol; 2017 Nov; 12(1):184. PubMed ID: 29166942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity Cancer.
    Ding D; Stokes W; Eguchi M; Hararah M; Sumner W; Amini A; Goddard J; Somerset H; Bradley C; McDermott J; Raben D; Karam SD
    JAMA Otolaryngol Head Neck Surg; 2019 Jan; 145(1):53-61. PubMed ID: 30452499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment results of postoperative radiotherapy on squamous cell carcinoma of the oral cavity: coexistence of multiple minor risk factors results in higher recurrence rates.
    Fan KH; Wang HM; Kang CJ; Lee LY; Huang SF; Lin CY; Chen EY; Chen IH; Liao CT; Chang JT
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1024-9. PubMed ID: 20610038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node ratio relationship to regional failure and distant metastases in oral cavity cancer.
    Hosni A; McMullen C; Huang SH; Xu W; Su J; Bayley A; Bratman SV; Cho J; Giuliani M; Kim J; Ringash J; Waldron J; Spreafico A; Weinreb I; de Almeida JR; Brown DH; Irish JC; O'Sullivan B; Goldstein DP; Hope A
    Radiother Oncol; 2017 Aug; 124(2):225-231. PubMed ID: 28838425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definitive (chemo)radiotherapy is a curative alternative for standard of care in advanced stage squamous cell carcinoma of the oral cavity.
    Elbers JBW; Al-Mamgani A; Paping D; van den Brekel MWM; Jóźwiak K; de Boer JP; Karakullukcu B; Verheij M; Zuur CL
    Oral Oncol; 2017 Dec; 75():163-168. PubMed ID: 29224815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
    Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].
    Qian W; Zhu G; Ji Q; Guo Y; Wang Y; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):217-22. PubMed ID: 24785284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-center retrospective study of the prognosis and treatment outcomes of Japanese oral squamous cell carcinoma patients with single lymph node metastasis and extra nodal extension.
    Hasegawa T; Yanamoto S; Otsuru M; Kakei Y; Okura M; Yamakawa N; Yamada SI; Ota Y; Umeda M; Kirita T; Kurita H; Ueda M; Komori T;
    J Surg Oncol; 2018 Jun; 117(8):1736-1743. PubMed ID: 29714825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative radiotherapy for patients at high risk of recurrence of oral cavity squamous cell carcinoma.
    Herman MP; Dagan R; Amdur RJ; Morris CG; Werning JW; Vaysberg M; Mendenhall WM
    Laryngoscope; 2015 Mar; 125(3):630-5. PubMed ID: 25376116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcomes in pT4 Tongue Carcinoma are Worse than in pT3 Disease: How Extrinsic Muscle Invasion Should be Considered?
    Liao CT; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Ng SH; Lin CH; Tsao CK; Kang CJ; Fang TJ; Huang SF; Chang KP; Yang LY; Yen TC
    Ann Surg Oncol; 2017 Sep; 24(9):2570-2579. PubMed ID: 28577181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative Radiotherapy.
    Noble AR; Greskovich JF; Han J; Reddy CA; Nwizu TI; Khan MF; Scharpf J; Adelstein DJ; Burkey BB; Koyfman SA
    Anticancer Res; 2016 Feb; 36(2):785-92. PubMed ID: 26851040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Curative effect analysis of postoperative concurrent chemoradiotherapy on early-stage cervical cancer patients with intermediate-risk factors].
    Tang Q; Tu YQ; Chen JH; Lyu XJ; Yan DD
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):462-466. PubMed ID: 29936774
    [No Abstract]   [Full Text] [Related]  

  • 19. The Therapeutic Benefit of Radical Resection for T4b Oral Cavity Squamous Cell Carcinoma with Partial or Complete Response After Radical Chemo-Intensity-Modulated Radiotherapy (IMRT).
    Fang FM; Chuang HC; Chou SY; Huang TL; Wang CJ; Lin YT; Chiu TJ; Lin WC; Li SH; Su YY; Chien CY
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):866-873. PubMed ID: 27613559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery.
    Zhou Y; Wang W; Tang J; Hu K; Zhang F
    BMC Cancer; 2024 Apr; 24(1):548. PubMed ID: 38689248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.